Payment overview · 2025
General Payments
$124.60
1 reported records · 1 companies
Healthcare provider profile · identity verified
Herbert A Stone, MD
Allopathic & Osteopathic Physicians|Emergency Medicine · SPANISH FORT, AL · NPI 1285667162
Verified facts
What the public records show
CMS Open Payments records show Herbert A Stone, MD received $124.60 in general payments during 2025 across 1 reported records.
Alpha Cognition USA, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Alpha Cognition USA, Inc. | Unresolved — no canonical attribution shown | $124.60 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $124.60 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Zunveyl Normalized: zunveyl |
Drug | Alpha Cognition USA, Inc. | $124.60 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 700 | 106 |
| Amlodipine Besylate | Amlodipine Besylate | 586 | 81 |
| Eliquis | Apixaban | 494 | 42 |
| Potassium Chloride | Potassium Chloride | 428 | 57 |
| Sertraline Hcl | Sertraline Hcl | 393 | 59 |
| Pantoprazole Sodium | Pantoprazole Sodium | 385 | 61 |
| Furosemide | Furosemide | 330 | 62 |
| Famotidine | Famotidine | 325 | 49 |
| Olanzapine | Olanzapine | 305 | 38 |
| Mirtazapine | Mirtazapine | 295 | 52 |
| Gabapentin | Gabapentin | 280 | 36 |
| Tramadol Hcl | Tramadol Hcl | 254 | 43 |
| Levothyroxine Sodium | Levothyroxine Sodium | 247 | 39 |
| Donepezil Hcl | Donepezil Hcl | 241 | 31 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 230 | 40 |
| Carvedilol | Carvedilol | 215 | 36 |
| Metformin Hcl | Metformin Hcl | 215 | 31 |
| Memantine Hcl | Memantine Hcl | 198 | 28 |
| Tamsulosin Hcl | Tamsulosin Hcl | 188 | 32 |
| Trazodone Hcl | Trazodone Hcl | 185 | 35 |
| Divalproex Sodium | Divalproex Sodium | 159 | 21 |
| Fluoxetine Hcl | Fluoxetine Hcl | 145 | 11 |
| Lisinopril | Lisinopril | 145 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 143 | 33 |
| Levetiracetam | Levetiracetam | 142 | 21 |
| Metoprolol Tartrate | Metoprolol Tartrate | 141 | 32 |
| Buspirone Hcl | Buspirone Hcl | 137 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 128 | 15 |
| Ondansetron Hcl | Ondansetron Hcl | 124 | 44 |
| Xarelto | Rivaroxaban | 123 | suppressed |
| Sucralfate | Sucralfate | 122 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 121 | 20 |
| Tizanidine Hcl | Tizanidine Hcl | 115 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 114 | 15 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 111 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 107 | 17 |
| Metoprolol Succinate | Metoprolol Succinate | 107 | 18 |
| Omeprazole | Omeprazole | 99 | 23 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 96 | 15 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 92 | 33 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 89 | 36 |
| Oxcarbazepine | Oxcarbazepine | 89 | suppressed |
| Lorazepam | Lorazepam | 87 | 20 |
| Ezetimibe | Ezetimibe | 84 | suppressed |
| Allopurinol | Allopurinol | 72 | 12 |
| Sodium Chloride | 0.9 % Sodium Chloride | 72 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 70 | suppressed |
| Entresto | Sacubitril/Valsartan | 69 | suppressed |
| Jardiance | Empagliflozin | 69 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 64 | 19 |
| Clonidine | Clonidine | 59 | suppressed |
| Losartan Potassium | Losartan Potassium | 59 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 59 | suppressed |
| Baclofen | Baclofen | 58 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 57 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 56 | 11 |
| Methenamine Hippurate | Methenamine Hippurate | 56 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 55 | suppressed |
| Prednisone | Prednisone | 53 | suppressed |
| Simvastatin | Simvastatin | 53 | suppressed |
| Risperidone | Risperidone | 52 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 51 | 13 |
| Latanoprost | Latanoprost | 51 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 49 | suppressed |
| Tradjenta | Linagliptin | 48 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 47 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 47 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 47 | 13 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 47 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 46 | 19 |
| Ibuprofen | Ibuprofen | 45 | suppressed |
| Nyamyc | Nystatin | 45 | 16 |
| Scopolamine | Scopolamine | 44 | 11 |
| Montelukast Sodium | Montelukast Sodium | 43 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 42 | suppressed |
| Aripiprazole | Aripiprazole | 41 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 41 | 17 |
| Glycopyrrolate | Glycopyrrolate | 41 | suppressed |
| Lactulose | Lactulose | 41 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 39 | 23 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Spironolactone | Spironolactone | 39 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 38 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 38 | 19 |
| Divalproex Sodium Er | Divalproex Sodium | 37 | suppressed |
| Haloperidol | Haloperidol | 37 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 35 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 34 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 34 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 34 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 34 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 33 | suppressed |
| Olanzapine Odt | Olanzapine | 32 | suppressed |
| Phenytoin | Phenytoin | 31 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 31 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 31 | suppressed |
| Clonazepam | Clonazepam | 30 | suppressed |
| Torsemide | Torsemide | 30 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 29 | 29 |
| Fluconazole | Fluconazole | 29 | 16 |
| Levofloxacin | Levofloxacin | 29 | 25 |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 29 | suppressed |
| Rexulti | Brexpiprazole | 27 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 26 | suppressed |
| Meloxicam | Meloxicam | 26 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 25 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 25 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 21 |
| Carbamazepine Er | Carbamazepine | 24 | suppressed |
| Ingrezza | Valbenazine Tosylate | 24 | suppressed |
| Novolog | Insulin Aspart | 24 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | suppressed |
| Finasteride | Finasteride | 23 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 23 | suppressed |
| Mupirocin | Mupirocin | 23 | 11 |
| Topiramate | Topiramate | 23 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 22 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 21 | suppressed |
| Atenolol | Atenolol | 21 | suppressed |
| Cefepime-Dextrose | Cefepime Hcl In Dextrose 5 % | 21 | suppressed |
| Gemtesa | Vibegron | 21 | suppressed |
| Irbesartan | Irbesartan | 21 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 20 | suppressed |
| Budesonide | Budesonide | 20 | suppressed |
| Ketoconazole | Ketoconazole | 20 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 20 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 20 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 19 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 19 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 19 | suppressed |
| Enulose | Lactulose | 19 | suppressed |
| Insulin Lispro | Insulin Lispro | 19 | suppressed |
| Meropenem-0.9% Nacl | Meropenem-0.9% Sodium Chloride | 19 | suppressed |
| Nystatin | Nystatin | 19 | 12 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 19 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 18 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Loxapine | Loxapine Succinate | 18 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 18 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 18 | suppressed |
| Acetic Acid | Acetic Acid | 17 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 17 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 17 | suppressed |
| Semglee (Yfgn) | Insulin Glargine-Yfgn | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 16 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 16 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 16 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 15 | suppressed |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 15 | suppressed |
| Alprazolam | Alprazolam | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Cephalexin | Cephalexin | 14 | 11 |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Glimepiride | Glimepiride | 13 | suppressed |
| Meropenem | Meropenem | 13 | suppressed |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Carbidopa-Levodopa-Entacapone | Carbidopa/Levodopa/Entacapone | 12 | suppressed |
| Cefdinir | Cefdinir | 12 | 11 |
| Humalog | Insulin Lispro | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Timolol Maleate | Timolol Maleate | 12 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | 11 |
| Benztropine Mesylate | Benztropine Mesylate | 11 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $124.60 · 1 records | Alpha Cognition USA, Inc. | Zunveyl | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error